HRT Financial’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-41,005
| Closed | -$1.22M | – | 2433 |
|
|
2025
Q1 | $1.22M | Sell |
41,005
-5,364
| -12% | -$160K | 0.01% | 890 |
|
|
2024
Q4 | $1.33M | Sell |
46,369
-56,282
| -55% | -$1.61M | 0.01% | 803 |
|
|
2024
Q3 | $3.97M | Buy |
+102,651
| New | +$3.97M | 0.02% | 529 |
|
|
2024
Q2 | – | Sell |
-98,586
| Closed | -$3.83M | – | 2158 |
|
|
2024
Q1 | $3.83M | Buy |
98,586
+49,984
| +103% | +$1.94M | 0.02% | 339 |
|
|
2023
Q4 | $1.5M | Sell |
48,602
-42,924
| -47% | -$1.32M | 0.01% | 738 |
|
|
2023
Q3 | $2.05M | Buy |
91,526
+12,646
| +16% | +$283K | 0.02% | 558 |
|
|
2023
Q2 | $1.7M | Buy |
78,880
+14,015
| +22% | +$301K | 0.02% | 639 |
|
|
2023
Q1 | $1.56M | Buy |
+64,865
| New | +$1.56M | 0.02% | 688 |
|
|
2022
Q4 | – | Sell |
-71,603
| Closed | -$1.15M | – | 2369 |
|
|
2022
Q3 | $1.15M | Buy |
71,603
+57,469
| +407% | +$921K | 0.01% | 800 |
|
|
2022
Q2 | $250K | Sell |
14,134
-701
| -5% | -$12.4K | ﹤0.01% | 2070 |
|
|
2022
Q1 | $302K | Sell |
14,835
-13,699
| -48% | -$279K | ﹤0.01% | 2006 |
|
|
2021
Q4 | $533K | Buy |
+28,534
| New | +$533K | ﹤0.01% | 1503 |
|
|
2021
Q3 | – | Sell |
-21,774
| Closed | -$514K | – | 3072 |
|
|
2021
Q2 | $514K | Buy |
+21,774
| New | +$514K | ﹤0.01% | 1666 |
|
|
2021
Q1 | – | Sell |
-16,681
| Closed | -$334K | – | 2526 |
|
|
2020
Q4 | $334K | Buy |
+16,681
| New | +$334K | 0.01% | 1164 |
|